These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36992900)

  • 1. Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of
    Zhao J; Liu H; Xia M; Chen Q; Wan L; Leng B; Tang C; Chen G; Liu Y; Zhang L; Liu H
    Drug Des Devel Ther; 2023; 17():887-900. PubMed ID: 36992900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Based on Network Pharmacology Tools to Investigate the Mechanism of
    Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
    Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
    [No Abstract]   [Full Text] [Related]  

  • 3. Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
    Zhang D; Dong Y; Lv J; Zhang B; Zhang X; Lin Z
    BMC Complement Med Ther; 2021 Jan; 21(1):38. PubMed ID: 33446184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Active Ingredients and Molecular Mechanisms of
    Jiang Y; Zhong M; Long F; Yang R
    Evid Based Complement Alternat Med; 2020; 2020():2361865. PubMed ID: 32015751
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of Glutamine-Glutamate/GABA cycle and potential target GLUD2 in alleviation of rheumatoid arthritis by Tripterygium hypoglaucum (levl.) Hutch based on metabolomics and molecular pharmacology.
    Long C; Yang Y; Wang Y; Zhang X; Zhang L; Huang S; Yang D; Qiao X; Yang Y; Guo Y
    J Ethnopharmacol; 2021 Dec; 281():114561. PubMed ID: 34454056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total alkaloids of Tripterygium hypoglaucum (levl.) Hutch inhibits tumor growth both in vitro and in vivo.
    Jiang X; Huang XC; Ao L; Liu WB; Han F; Cao J; Zhang DY; Huang CS; Liu JY
    J Ethnopharmacol; 2014; 151(1):292-8. PubMed ID: 24212079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Artemisinin Against IgA Nephropathy via AKT/Nrf2 Pathway by Bioinformatics and Experimental Validation.
    Yang WG; Sun A; Zhu R; Liu N; He WJ; Liu LL
    Drug Des Devel Ther; 2023; 17():1679-1697. PubMed ID: 37309415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway.
    Zhao L; Lan Z; Peng L; Wan L; Liu D; Tan X; Tang C; Chen G; Liu H
    Cell Prolif; 2022 Sep; 55(9):e13278. PubMed ID: 35733381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma.
    Pan YF; Zhong L; Wang M; Jiang TY; Lin YK; Chen YB; Li X; Hu HP; Zhou HB; Yan HZ; Dong LW
    Phytomedicine; 2024 Aug; 131():155790. PubMed ID: 38851099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy.
    Chen Y; Lu M; Lin M; Gao Q
    Lupus; 2024 Apr; 33(4):347-356. PubMed ID: 38285068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii.
    Dai M; Peng W; Lin L; Wu ZE; Zhang T; Zhao Q; Cheng Y; Lin Q; Zhang B; Liu A; Rao Q; Huang J; Zhao J; Gonzalez FJ; Li F
    Phytomedicine; 2023 Dec; 121():155054. PubMed ID: 37738906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy.
    Li Y; Xia M; Peng L; Liu H; Chen G; Wang C; Yuan D; Liu Y; Liu H
    Int J Biol Sci; 2021; 17(13):3343-3355. PubMed ID: 34512151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy.
    Li C; Shi J; Zhao Y
    J Cell Biochem; 2018 Jun; 119(6):4607-4614. PubMed ID: 29266359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Mechanism of Zhibaidihuang Decoction against IgA Nephropathy Using Network Pharmacology and Molecular Docking Analyses.
    Deng X; Luo Y; Lu M; Guan T; Li Y; Guo X
    Tohoku J Exp Med; 2022 Dec; 259(1):37-47. PubMed ID: 36288951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the molecular mechanism of the effect of ginkgo folium on the treatment of IgA nephropathy using network pharmacology and molecular docking.
    Ru X; Zhang Y; Gao Y; Wang H
    Nat Prod Res; 2022 Nov; 36(22):5836-5841. PubMed ID: 34927488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis.
    Cai B; Qi M; Zhang X; Zhang D
    Drug Des Devel Ther; 2024; 18():3121-3141. PubMed ID: 39071814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated study reveals mechanism of Tripterygium Wilfordii against cholangiocarcinoma based on bioinformatics approaches and molecular dynamics simulation.
    Zhao Y; Guo J
    Comput Biol Chem; 2024 Apr; 109():108030. PubMed ID: 38387122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro "benefit-risk" evaluation and network regulation mechanism of Colquhounia Root Tablets and its key material basis].
    Wang KX; Mao X; Zhang YG; Wu AG; Su XH; Wang JR; Cai BL; Lin N; Huang F
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6438-6449. PubMed ID: 36604890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations.
    Ling J; Huang Y; Sun Z; Guo X; Chang A; Pan J; Zhuo X
    Front Pharmacol; 2022; 13():996728. PubMed ID: 36506508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.